ISSN 2052-787X
Accepting Submissions
..................................................................................
OA Inflammation is a multidisciplinary open access 'peer reviewed' journal that publishes basic and clinical research concerning all aspects of inflammation and inflammatory disease including:
Physiology Biochemistry Cell Biology
Molecular Basis Pharmacology Clinical
OA Inflammation is committed to publishing high quality 'peer reviewed' manuscripts that illustrate the most important and 'cutting edge' developments in all areas of inflammation.
We will facilitate article submission, rapid article quality assurance through 'peer review', article formatting and processing to a final product which will allow high visibility, impact and provoke debate.
This journal has adopted the following models:
- Creative Commons Attribution License (CC-BY 2.0 UK)
- Publication Integrity and Ethics (P.I.E.) Guidelines
- Ethical Rules of Disclosure of the Association for Medical Ethics (AME)
- ICMJE Recommendations of the International Committee of Medical Journal Editors (ICMJE)
- Editorial Policy Statements of the Council of Science Editors (CSE)
Tracked/indexed by:
Google Scholar, JournalSeek, CrossRef, EZB Nutzeranfragen, RoMEO, AcademicKeys, CNKI, J-Gate
OAPL (UK) archiving provider: British Library
Our publisher has negotiated a discount for its editors, reviewers and authors to undertake (distant learning- fully online) short courses related to research integrity and publication ethics, law and medical ethics, research governance, good ethical practice, leadership and management. These courses are approved by the Publication Integrity & Ethics.
The Association for Medical Ethics promotes the care of patients absent of any consideration of financial gain or loss based on choice of surgical equipment, implant, manufacturer, hospital or surgery center.
OAPL has adopted the Ethical Rules of Disclosure of the Association for Medical Ethics for all its journals.
A UK-based not-for-profit organization promoting integrity and ethics in the publishing sector through its guidelines and code of conduct.
P.I.E.'s main aim is to pave the way for a better publishing ethical environment that sets out the standards of a good and ethical editorial behaviour.
Whilst P.I.E. (π) promotes editorial freedom, at the same time, it also ensures that this freedom is not violated by editorial misconduct and plagiarism.
OAPL authors may choose to include the
OAPL standard ethics statements
in their submitted articles. It is assumed that all submitted original research studies, research studies, hypothesis, methodologies, short communications, case studies, case reports & case series have been conducted to the highest ethical standards.
Kalra N, Ishmael FT. Cross-talk between vitamin D, estrogen and corticosteroids in glucocorticoid resistant asthma. OA Inflammation 2014 Feb 22;2(1):2.
High ImpactTsuji K, Nozaki K, Aoki T. NF-kB as a crucial factor for intracranial aneurysm formation and the potential of statins as drugs for intracranial aneurysm treatment through their anti-NF-kB effect. OA Inflammation 2014 Jan 18;2(1):1.
High ImpactVivanco-Cid H, Mellado-S?nchez G, Sumoza-Toledo A. Transient receptor potential melastatin-2 channel and inflammation. OA Inflammation 2013 Nov 01;1(2):12.
High ImpactAlhagamhmad MH, Lemberg DA, Day AS, Leach ST. Therapeutic and preventative anti-inflammatory benefits of curcumin in vitro. OA Inflammation 2013 Oct 01;1(2):11.
High ImpactGupta R, Chattopadhyay D. Seeing inflammation through the innate immune eye. OA Inflammation 2013 Sep 01;1(1):10.
High ImpactEthier C, Davoine F. A gap in cell death knowledge: Is necroptosis of eosinophils involved in allergic airway inflammation? OA Inflammation 2013 Aug 01;1(1):9.
High ImpactEisenhut M. The pathogenesis of cerebral vasospasm in bacterial meningitis. OA Inflammation 2013 Jul 01;1(1):8.
High ImpactMackesy DZ, Goalstone ML. Nuclear-factor kB p65 is a mediator of insulin and tumour necrosis factor-alpha stimulated vascular cell adhesion molecule-1 expression in vascular endothelial cells. OA Inflammation 2013 Jun 01;1(1):7.
High ImpactHamzaoui K, Hamzaoui A. Vitamin D level and potential impact on immune cells in Beh?et?s disease. OA Inflammation 2013 Jun 01;1(1):6.
High ImpactGao HY, Wang JH Antihepatic fibrosis effects of traditional Chinese medicine: A review. OA Inflammation 2013 May 01;1(1):5.
High ImpactDimitrova P, Ivanovska N. Tyrphostins as a promising therapeutic tool in inflammation-related conditions. OA Inflammation 2013 May 01;1(1):4.
High ImpactGiambelluca MS, Rollet-Labelle E, Bertheau-Mailhot G, Laflamme C, Pouliot M. Post-transcriptional regulation of tumour necrosis factor alpha biosynthesis: Relevance to the pathophysiology of rheumatoid arthritis. OA Inflammation 2013 Apr 01;1(1):3.
High ImpactRivers-Auty J, Bhatia M. Hydrogen sulphide, systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome following sepsis. OA Inflammation 2013 Apr 01;1(1):2.
High ImpactGiambelluca MS, Rollet-Labelle E, Bertheau-Mailhot G, Laflamme C, Pouliot M. Post-transcriptional regulation of tumour necrosis factor alpha biosynthesis: Relevance to the pathophysiology of rheumatoid arthritis. OA Inflammation 2013 Apr 01;1(1):3.
High ImpactKalra N, Ishmael FT. Cross-talk between vitamin D, estrogen and corticosteroids in glucocorticoid resistant asthma. OA Inflammation 2014 Feb 22;2(1):2.
High ImpactVivanco-Cid H, Mellado-S?nchez G, Sumoza-Toledo A. Transient receptor potential melastatin-2 channel and inflammation. OA Inflammation 2013 Nov 01;1(2):12.
High ImpactRivers-Auty J, Bhatia M. Hydrogen sulphide, systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome following sepsis. OA Inflammation 2013 Apr 01;1(1):2.
High ImpactAlhagamhmad MH, Lemberg DA, Day AS, Leach ST. Therapeutic and preventative anti-inflammatory benefits of curcumin in vitro. OA Inflammation 2013 Oct 01;1(2):11.
High ImpactSlomiany BL, Slomiany A. Role of epidermal growth factor receptor transactivation in the amplification of Helicobacter pylori-elicited induction in gastric mucosal expression of cyclooxygenase-2 and inducible nitric oxide synthase. OA Inflammation 2013 Apr 01;1(1):1.
High ImpactTsuji K, Nozaki K, Aoki T. NF-kB as a crucial factor for intracranial aneurysm formation and the potential of statins as drugs for intracranial aneurysm treatment through their anti-NF-kB effect. OA Inflammation 2014 Jan 18;2(1):1.
High ImpactHamzaoui K, Hamzaoui A. Vitamin D level and potential impact on immune cells in Beh?et?s disease. OA Inflammation 2013 Jun 01;1(1):6.
High ImpactGao HY, Wang JH Antihepatic fibrosis effects of traditional Chinese medicine: A review. OA Inflammation 2013 May 01;1(1):5.
High ImpactEisenhut M. The pathogenesis of cerebral vasospasm in bacterial meningitis. OA Inflammation 2013 Jul 01;1(1):8.
High ImpactGupta R, Chattopadhyay D. Seeing inflammation through the innate immune eye. OA Inflammation 2013 Sep 01;1(1):10.
High ImpactEthier C, Davoine F. A gap in cell death knowledge: Is necroptosis of eosinophils involved in allergic airway inflammation? OA Inflammation 2013 Aug 01;1(1):9.
High ImpactDimitrova P, Ivanovska N. Tyrphostins as a promising therapeutic tool in inflammation-related conditions. OA Inflammation 2013 May 01;1(1):4.
High ImpactKalra N, Ishmael FT. Cross-talk between vitamin D, estrogen and corticosteroids in glucocorticoid resistant asthma. OA Inflammation 2014 Feb 22;2(1):2.
High ImpactTsuji K, Nozaki K, Aoki T. NF-kB as a crucial factor for intracranial aneurysm formation and the potential of statins as drugs for intracranial aneurysm treatment through their anti-NF-kB effect. OA Inflammation 2014 Jan 18;2(1):1.
High ImpactVivanco-Cid H, Mellado-S?nchez G, Sumoza-Toledo A. Transient receptor potential melastatin-2 channel and inflammation. OA Inflammation 2013 Nov 01;1(2):12.
High ImpactAlhagamhmad MH, Lemberg DA, Day AS, Leach ST. Therapeutic and preventative anti-inflammatory benefits of curcumin in vitro. OA Inflammation 2013 Oct 01;1(2):11.
High ImpactGupta R, Chattopadhyay D. Seeing inflammation through the innate immune eye. OA Inflammation 2013 Sep 01;1(1):10.
High ImpactEthier C, Davoine F. A gap in cell death knowledge: Is necroptosis of eosinophils involved in allergic airway inflammation? OA Inflammation 2013 Aug 01;1(1):9.
High ImpactEisenhut M. The pathogenesis of cerebral vasospasm in bacterial meningitis. OA Inflammation 2013 Jul 01;1(1):8.
High ImpactMackesy DZ, Goalstone ML. Nuclear-factor kB p65 is a mediator of insulin and tumour necrosis factor-alpha stimulated vascular cell adhesion molecule-1 expression in vascular endothelial cells. OA Inflammation 2013 Jun 01;1(1):7.
High ImpactHamzaoui K, Hamzaoui A. Vitamin D level and potential impact on immune cells in Beh?et?s disease. OA Inflammation 2013 Jun 01;1(1):6.
High ImpactGao HY, Wang JH Antihepatic fibrosis effects of traditional Chinese medicine: A review. OA Inflammation 2013 May 01;1(1):5.
High ImpactDimitrova P, Ivanovska N. Tyrphostins as a promising therapeutic tool in inflammation-related conditions. OA Inflammation 2013 May 01;1(1):4.
High ImpactGiambelluca MS, Rollet-Labelle E, Bertheau-Mailhot G, Laflamme C, Pouliot M. Post-transcriptional regulation of tumour necrosis factor alpha biosynthesis: Relevance to the pathophysiology of rheumatoid arthritis. OA Inflammation 2013 Apr 01;1(1):3.
High ImpactRivers-Auty J, Bhatia M. Hydrogen sulphide, systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome following sepsis. OA Inflammation 2013 Apr 01;1(1):2.
High ImpactRead about the
OAPL (UK) Code of Conduct for Editors
OAPL (UK) Press Centre- Publishing Director
OAPL (UK) and its journals support the following reporting guidelines for specific study designs:
CONSORT: Consolidated Standards of Reporting Trials
STARD: STAndards for the Reporting of Diagnostic accuracy studies
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
STROBE: STrengthening the Reporting of OBservational studies in Epidemiology
MOOSE: Meta-analysis of Observational Studies in Epidemiology
MIBBI: Minimum Information for Biological and Biomedical Investigations
ICTRP: International Clinical Trials Registry Platform
PROSPERO: International prospective register of systematic reviews
Copyright © 2013 - 2020 OAPL (UK)